Antihyperglycemic Effect of Ginkgo biloba Extract in Streptozotocin-Induced Diabetes in Rats

Table 2

Effect of GBE treatment on serum lipid profile of rats in experimental groups.

	N group	D group	N + G group	D + LG group	D + MG group	D + HG group	D + GLI group
TG (mmol/L)	1.48 ± 0.35	2.32 ± 0.51^a	1.46 ± 0.38^b	1.75 ± 0.40^c	1.65 ± 0.41^b	1.52 ± 0.28^b	1.36 ± 0.40^b
TC (mmol/L)	1.69 ± 0.26	2.71 ± 0.48^a	1.61 ± 0.30^b	2.02 ± 0.51^b	1.83 ± 0.44^b	1.77 ± 0.33^b	1.65 ± 0.31^b
HDL-C (mmol/L)	1.35 ± 0.23	0.92 ± 0.30^a	1.21 ± 0.28^b	0.98 ± 0.25	1.19 ± 0.23^c	1.28 ± 0.30^c	1.20 ± 0.22^b
LDL-C (mmol/L)	0.56 ± 0.09	0.73 ± 0.11^a	0.51 ± 0.08^b	0.68 ± 0.09	0.67 ± 0.03	0.62 ± 0.06^c	0.57 ± 0.10^b

Values are means ± SD for 10 rats in each group. N group: normal control; D group: diabetes group; N + G group: normal control plus GBE; D + LG group: diabetes plus low GBE treatment; D + MG group: diabetes plus middle GBE treatment; D + HG group: diabetes plus high GBE treatment; D + GLI group: diabetes plus glibenclamide treatment.
^aIndicates statistical significance of 𝑃<0.01 compared to N group; ^b𝑃<0.01 compared to D group.
^c𝑃<0.05 compared to D group.